Supplemental Reports Available for Select Tests [Updated]
Starting this week, a select number of Mayo Medical Laboratories test results will include a supplemental report, providing more details and/or improved format than what is currently possible with our laboratory information system. This new functionality, to be available for 13 tests initially, will enable you to view an additional report, which may include more information, charts, images and other enriched information.
How will you know there is a supplemental report?
There are four ways to access supplemental reports:
- Subscribe to MayoAccess email notifications by contacting Client Support or your Regional Service Representative.
- Search for results in the “lab reports” view in MayoAccess. Tests with supplemental reports will be flagged with an “RI” symbol, which will be displayed in the search result grid.
- Print your test reports in MayoAccess and any supplemental report will be included in the print out.
- Use the hyperlink included in the test result returned to your laboratory information system or MayoAccess.
How will supplemental reports be transmitted to interfaces?
The message and hyperlink to the report will be sent your interface in an NTE field. Copy and paste the link into Internet Explorer to retrieve that specific report or log into MayoAccess and search for that patient report.
List of tests with supplemental reports
|JAK2 V617F Mutation Detection, Varies||Test Changes|
|BCR/ABL, Tyrosine Kinase Inhibitor Resistance, Kinase Domain Mutation Screen||Test Changes|
|BCR/ABL, p210, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Chronic Myelogenous Leukemia (CML)||Test Changes|
|Plasma Cell Assessment, Blood||Test Changes|
|Therapeutic Antibody by Flow Cytometry||Test Changes|
|Plasma Cell DNA Content and Proliferation, Bone Marrow||Test Changes|
|JAK2 V617F Mutation Detection, Bone Marrow||Test Changes|
|JAK2 V617F Mutation Detection, Blood||Test Changes|
|Leukemia/Lymphoma Immunophenotyping by Flow Cytometry||Test Changes|
|Hematologic Disorders, Leukemia/Lymphoma; Flow Hold Varies||Test Changes|
|CLL Monitoring, MRD Detection, Blood||Test Changes|
|PNH, PI-Linked Antigen, Blood||Test Changes|
|CLL Monitoring, MRD Detection FLIP, see #60490||Test Changes|
|ZAP-70, Chronic Lymphocytic Leukemia (CLL) Prognosis||Test Changes|
|Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue||Test Changes|